feed,title,long_url,short_url
SeekingAlpha,Nabriva Therapeutics expects mid-to-high single digit revenue growth sequentially in Q4,https://seekingalpha.com/news/3786736,
SeekingAlpha,KKR closes health care strategic growth fund at $4.0B,https://seekingalpha.com/news/3786735,
SeekingAlpha,Epizyme jumps after product revenue shows strong sequential growth: Q4 Prelim,https://seekingalpha.com/news/3786734,
